Obanda Benear Apollo, Cook Elizabeth A J, Fèvre Eric M, Bebora Lilly, Ogara William, Wang Shu-Hua, Gebreyes Wondwossen, Ngetich Ronald, Wandede Dolphine, Muyodi Johnstone, Blane Beth, Coll Francesc, Harrison Ewan M, Peacock Sharon J, Gitao George C
Department of Veterinary Pathology, Microbiology and Parasitology, University of Nairobi, Nairobi P.O. Box 29053-00625, Kenya.
Global One Health Initiative, Office of International Affairs, The Ohio State University, Columbus, OH 43210, USA.
Pathogens. 2022 Dec 9;11(12):1504. doi: 10.3390/pathogens11121504.
is an important pathogen associated with hospital, community, and livestock-acquired infections, with the ability to develop resistance to antibiotics. Nasal carriage by hospital inpatients is a risk for opportunistic infections. Antibiotic susceptibility patterns, virulence genes and genetic population structure of nasal isolates, from inpatients at Busia County Referral Hospital (BCRH) were analyzed. A total of 263 inpatients were randomly sampled, from May to July 2015. The majority of inpatients (85.9%) were treated empirically with antimicrobials, including ceftriaxone (65.8%) and metronidazole (49.8%). Thirty isolates were cultured from 29 inpatients with a prevalence of 11% (10.3% methicillin-susceptible (MSSA), 0.8% methicillin resistant (MRSA)). Phenotypic and genotypic resistance was highest to penicillin-G (96.8%), trimethoprim (73.3%), and tetracycline (13.3%) with 20% of isolates classified as multidrug resistant. Virulence genes, Panton-Valentine leukocidin (), toxic shock syndrome toxin-1 (), and gene were detected in 16.7%, 23.3% and 3.3% of isolates. Phylogenetic analysis showed 4 predominant clonal complexes CC152, CC8, CC80, and CC508. This study has identified that inpatients of BCRH were carriers of harbouring virulence genes and resistance to a range of antibiotics. This may indicate a public health risk to other patients and the community.
是一种与医院、社区和家畜获得性感染相关的重要病原体,具有对抗生素产生耐药性的能力。医院住院患者的鼻腔携带是机会性感染的一个风险因素。对布西亚县转诊医院(BCRH)住院患者的鼻腔分离株的抗生素敏感性模式、毒力基因和遗传种群结构进行了分析。2015年5月至7月,共随机抽取了263名住院患者。大多数住院患者(85.9%)接受了经验性抗菌治疗,包括头孢曲松(65.8%)和甲硝唑(49.8%)。从29名住院患者中培养出30株分离株,患病率为11%(甲氧西林敏感(MSSA)为10.3%,耐甲氧西林(MRSA)为0.8%)。对青霉素-G(96.8%)、甲氧苄啶(73.3%)和四环素(13.3%)的表型和基因型耐药性最高,20%的分离株被归类为多重耐药。在16.7%、23.3%和3.3%的分离株中检测到毒力基因、杀白细胞素(PVL)、中毒性休克综合征毒素-1(TSST-1)和肠毒素基因。系统发育分析显示有4个主要的克隆复合体CC152、CC8、CC80和CC508。这项研究已经确定,BCRH的住院患者是携带毒力基因并对多种抗生素耐药的携带者。这可能表明对其他患者和社区存在公共卫生风险。